Calmune Corporation is a privately held biotechnology company developing antibody therapeutics to address unmet clinical needs for the betterment of human health. The company’s proprietary technologies, together with the founding scientists’ understanding of antibody biology and Calmune’s highly innovative discovery program, provide a foundation for rapid development of outstanding novel antibody products.